Morbidity of osteoporosis--can estrogen use make a public health impact?
The personal morbidity and economic burden associated with osteoporosis is substantial. Estrogen has been shown to have positive effects on the prevention and treatment of this disabling disease. Information is available with regard to when to initiate estrogen therapy, how long to maintain treatment, and how best to identify those women who will benefit most from its use.
Hartmann
D M
DM
University of Rochester Medical Center/Strong Memorial Hospital, Department of Obstetrics and Gynecology, NY 14642, USA.
D000368:Aged; D017281:Cost of Illness; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D010349:Patient Compliance; D018579:Patient Selection; D011634:Public Health; D016387:Women's Health